Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound‐guided fine needle aspiration
- 29 April 2010
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 60 (5), 358-364
- https://doi.org/10.1111/j.1440-1827.2010.02527.x
Abstract
Endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) has enabled clinicians to histologically diagnose pancreatic tumors. However, EUS‐FNA specimens often result in tiny fragmented tissues, so auxiliary utilities are necessary. Using immunostaining of CK7, CDX2, neuroendocrine markers and KRAS mutation analysis, we examined 57 FNA cell block sections and 61 surgically‐resected specimens (25 invasive ductal carcinomas, 25 endocrine tumors, and 11 acinar cell tumors). In the majority of the matched pairs, the diagnoses between EUS‐FNA and surgical specimens were concordant using the following criteria: neuroendocrine markers negative, CK7 positive, and mutated KRAS gene for invasive ductal carcinomas; neuroendocrine markers diffusely positive, CK7 and CDX2 negative, and wild‐type KRAS gene for well‐differentiated endocrine tumors; and neuroendocrine markers no more than focal positive, CK7 and CDX2 with various staining patterns, and wild‐type KRAS gene for acinar cell carcinomas. Expression of CK7 and/or CDX2 in addition to KRAS mutations were occasionally seen in endocrine carcinomas, but not in well‐differentiated endocrine tumors, suggesting that ductal differentiation in an endocrine tumor may be a predictor of aggressive disease. The usefulness of these markers was confirmed using 13 additional pancreatic tumors, prospectively. Although minimal in selection, these markers are helpful in making diagnosis from EUS‐FNA specimens of the major pancreatic tumors.Keywords
This publication has 24 references indexed in Scilit:
- Membrane loss and aberrant nuclear localization of E‐cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E‐cadherin moleculeHistopathology, 2008
- Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?Journal of Clinical Oncology, 2007
- Acinar Cell Carcinoma of the PancreasPancreas, 2007
- Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreasLaboratory Investigation, 2007
- A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung CancerThe Journal of Molecular Diagnostics, 2006
- AssessingEGFRMutationsThe New England Journal of Medicine, 2006
- Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and futureThe Esophagus, 2005
- CK20 expression, CDX2 expression, K‐ras mutation, and goblet cell morphology in a subset of lung adenocarcinomasThe Journal of Pathology, 2004
- Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patientsJournal of Gastrointestinal Surgery, 1998
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988